Stock Movers: Curaleaf, Southwest, Texas Instruments (Podcast)

Curaleaf and other cannabis stocks surged after the U.S. Justice Department reclassified state-regulated marijuana from Schedule I to Schedule III, a major regulatory shift that could support legal sales. Southwest fell after missing quarterly profit and revenue expectations and withholding full-year profit guidance amid higher fuel costs tied to Middle East conflict. Texas Instruments jumped sharply after forecasting Q2 revenue of $5.0B-$5.4B, well above the $4.85B consensus, driven by strong data center and industrial demand.

Analysis

TXN’s guide-up is more important as a signal than as a one-day rerating. The market is finally seeing a bifurcation inside semis: analog and industrial exposure are stabilizing earlier than consensus, while the AI-heavy narrative continues to dominate multiples. That matters because a sustained capex cycle in data centers and factory automation tends to lift not just TXN, but also the broader industrial semiconductor complex with a 2-3 quarter lag.

The bigger second-order effect is on the cycle debate. If management is already seeing enough visibility to outpace estimates by a meaningful margin, the downside scenario for the analog group likely shifts from “inventory correction” to “earnings trough already behind us.” That should pressure short positions in names that were positioned for a prolonged digestion phase, especially where valuation assumes flat-to-down revenue for the next 6-12 months.

LUV remains in a far less forgiving setup. Fuel is the key variable, but the real issue is that carriers with weaker pricing power cannot fully pass through a sudden input shock without sacrificing load factors, so margin risk can compound faster than the market models. The guidance non-update also suggests management is not confident enough to anchor the Street, which usually means estimate dispersion stays high and the stock remains a trading vehicle rather than a durable long until fuel or fares normalize.

The cannabis move is more of a sector repricing than a fundamentals reset: a Schedule III shift improves financing and tax optics, but it does not immediately solve banking, interstate commerce, or federal enforcement uncertainty. The consensus is likely overstating near-term earnings uplift and understating how slowly regulatory translation hits cash flow; expect the first-order rally to fade unless there is a follow-through rulemaking path over the next 3-9 months.

Key Decisions for Investors

• Long TXN on pullbacks over the next 1-3 sessions; pair against a weaker analog peer basket. Risk/reward favors a 3-5% upside extension if the market starts pricing a broader industrial semi recovery.
• Buy TXN call spreads into any post-earnings consolidation for a 1-2 month horizon. Best setup is a limited-risk expression on continued estimate revisions rather than chasing the gap higher.
• Short LUV tactically for 1-4 weeks or hedge with airline-sector exposure if holding travel names. Fuel-driven margin compression and no guide raise make it vulnerable to another leg lower if crude stays elevated.
• Avoid treating the cannabis rally as a buy-and-hold signal; consider fading strength in the most levered names over 1-3 weeks unless regulatory follow-through appears. The trade is vulnerable to air-pocket reversals once novelty fades.
• If long industrial cyclicals, add semi exposure via TXN as a lower-beta confirmation trade rather than chasing higher-multiple AI names. The relative-value expression offers cleaner risk/reward if the capex upcycle broadens.